ahlam1399
07-13-2016, 02:50 AM
UPDATE 3-U.S. FDA panel backs Amgen copy of AbbVie arthritis drug Humira
July 12 (Reuters) - Amgen Inc's cheaper version ofAbbVie's top-selling arthritis drug Humira is highlysimilar to the original and should be approved, an advisorypanel to the U.S. Food and Drug...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=n56yLXHD1iI:pIfbGzsP9ps:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=n56yLXHD1iI:pIfbGzsP9ps:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=n56yLXHD1iI:pIfbGzsP9ps:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=n56yLXHD1iI:pIfbGzsP9ps:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=n56yLXHD1iI:pIfbGzsP9ps:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/n56yLXHD1iI
July 12 (Reuters) - Amgen Inc's cheaper version ofAbbVie's top-selling arthritis drug Humira is highlysimilar to the original and should be approved, an advisorypanel to the U.S. Food and Drug...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=n56yLXHD1iI:pIfbGzsP9ps:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=n56yLXHD1iI:pIfbGzsP9ps:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=n56yLXHD1iI:pIfbGzsP9ps:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=n56yLXHD1iI:pIfbGzsP9ps:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=n56yLXHD1iI:pIfbGzsP9ps:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/n56yLXHD1iI